Inglés

Eligibility Criteria

6 formularios  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent file includes subject IDs and their consent group information.
    3. The pedigree table includes family ID, subject ID, father and mother ID, and subject gender, to link subjects of the same family.
    4. This subject sample mapping file contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
    5. The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status.
    6. The sample attributes table includes body site where sample was collected, analyte type, tumor status, and genotyping center.
Inclusion and exclusion criteria
Descripción

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Subjects were included if they were members of the original GeneSTAR Study population and were over 21 years of age. Subjects were excluded if they developed diabetes, cardiovascular disease, and any new known bleeding disorder, AIDS, advanced cancer, cancer under treatment or autoimmune diseases. Women who were pregnant when first recruited with consent will be deferred until 6 months after delivery, so they were not excluded, but did not give a blood sample during their pregnancy. Subjects with certain conditions that might be influenced by taking a 100cc volume of blood have already been pre-screened in GeneSTAR and were not eligible if they had blood dyscrasias, anemia, bleeding disorder or any contraindications to phlebotomy.
Descripción

Subjects were included if they were members of the original GeneSTAR Study population and were over 21 years of age. Subjects were excluded if they developed diabetes, cardiovascular disease, and any new known bleeding disorder, AIDS, advanced cancer, cancer under treatment or autoimmune diseases. Women who were pregnant when first recruited with consent will be deferred until 6 months after delivery, so they were not excluded, but did not give a blood sample during their pregnancy. Subjects with certain conditions that might be influenced by taking a 100cc volume of blood have already been pre-screened in GeneSTAR and were not eligible if they had blood dyscrasias, anemia, bleeding disorder or any contraindications to phlebotomy.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C1512693
UMLS CUI [1,3]
C2348561
UMLS CUI [1,4]
C0001779
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C1334965
UMLS CUI [2,3]
C0011849
UMLS CUI [2,4]
C0007222
UMLS CUI [2,5]
C0005779
UMLS CUI [2,6]
C0001175
UMLS CUI [2,7]
C0877373
UMLS CUI [2,8]
C0920425
UMLS CUI [2,9]
C0004364
UMLS CUI [3,1]
C0033011
UMLS CUI [3,2]
C2949735
UMLS CUI [3,3]
C0021430
UMLS CUI [3,4]
C0205421
UMLS CUI [3,5]
C4699371
UMLS CUI [4,1]
C0871117
UMLS CUI [4,2]
C4086268
UMLS CUI [4,3]
C0190979
UMLS CUI [4,4]
C1555471
UMLS CUI [4,5]
C0018939
UMLS CUI [4,6]
C0002871
UMLS CUI [4,7]
C0005779
UMLS CUI [4,8]
C0522473
UMLS CUI [4,9]
C0005857
Volver a la parte superior de la página

Similar models

Eligibility Criteria

6 formularios
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent file includes subject IDs and their consent group information.
    3. The pedigree table includes family ID, subject ID, father and mother ID, and subject gender, to link subjects of the same family.
    4. This subject sample mapping file contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
    5. The subject phenotype table includes age, sex, race, visit number, BMI, hypertension status (n=4 variables; self-reported, measured blood pressure, and medication), diabetic status (n=2 variables; glucose levels and medication), lipid measurements (n=4 variables; TC, TG, HDL, and LDL), cbc measurements (n=23 variables), whole blood measurements (n=22 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), platelet rich plasma measurements (n=47 variables; arachidonic acid, ADP/ATP, collagen/epineprhine/thromboxane B2, aggregation, all corrected for platelet counts), urine measurements (n=1 variable; thromboxane B2 adjusted for urinary creatinine), and current smoking status.
    6. The sample attributes table includes body site where sample was collected, analyte type, tumor status, and genotyping center.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Subjects were included if they were members of the original GeneSTAR Study population and were over 21 years of age. Subjects were excluded if they developed diabetes, cardiovascular disease, and any new known bleeding disorder, AIDS, advanced cancer, cancer under treatment or autoimmune diseases. Women who were pregnant when first recruited with consent will be deferred until 6 months after delivery, so they were not excluded, but did not give a blood sample during their pregnancy. Subjects with certain conditions that might be influenced by taking a 100cc volume of blood have already been pre-screened in GeneSTAR and were not eligible if they had blood dyscrasias, anemia, bleeding disorder or any contraindications to phlebotomy.
Item
Subjects were included if they were members of the original GeneSTAR Study population and were over 21 years of age. Subjects were excluded if they developed diabetes, cardiovascular disease, and any new known bleeding disorder, AIDS, advanced cancer, cancer under treatment or autoimmune diseases. Women who were pregnant when first recruited with consent will be deferred until 6 months after delivery, so they were not excluded, but did not give a blood sample during their pregnancy. Subjects with certain conditions that might be influenced by taking a 100cc volume of blood have already been pre-screened in GeneSTAR and were not eligible if they had blood dyscrasias, anemia, bleeding disorder or any contraindications to phlebotomy.
boolean
C0681850 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C2348561 (UMLS CUI [1,3])
C0001779 (UMLS CUI [1,4])
C2828389 (UMLS CUI [2,1])
C1334965 (UMLS CUI [2,2])
C0011849 (UMLS CUI [2,3])
C0007222 (UMLS CUI [2,4])
C0005779 (UMLS CUI [2,5])
C0001175 (UMLS CUI [2,6])
C0877373 (UMLS CUI [2,7])
C0920425 (UMLS CUI [2,8])
C0004364 (UMLS CUI [2,9])
C0033011 (UMLS CUI [3,1])
C2949735 (UMLS CUI [3,2])
C0021430 (UMLS CUI [3,3])
C0205421 (UMLS CUI [3,4])
C4699371 (UMLS CUI [3,5])
C0871117 (UMLS CUI [4,1])
C4086268 (UMLS CUI [4,2])
C0190979 (UMLS CUI [4,3])
C1555471 (UMLS CUI [4,4])
C0018939 (UMLS CUI [4,5])
C0002871 (UMLS CUI [4,6])
C0005779 (UMLS CUI [4,7])
C0522473 (UMLS CUI [4,8])
C0005857 (UMLS CUI [4,9])
Volver a la parte superior de la página